RENO, Nev. - nvtip -- VisualMED Clinical Solutions Corp. (The "Company") (PINKSHEETS: VMCS) announces that it has entered into a new agreement with AI research company Advanced Intelligence Medicorum Solutions Inc. of Montreal, Canada in order to develop new applications for patients at risk. These applications would rely on artificial intelligence and machine learning in order to provide protection from medication dangers, a leading cause of death in North America and Europe. Advanced Intelligent Medicorum has been developing AI concept with support from Montreal Universities which are world leaders in machine leaning research. The purpose of these new designs is to tackle a public health nightmare in which cumulative deadly side effects result in millions of avoidable deaths every year.

Some 200 million  North Americans and Europeans take 5 prescription drugs or more every day with the attendant risk of deadly drug- drug interaction or other medication errors. According to the National institute of health multiple medication interactions are leading cause of complications and premature death in the US.

More on nvtip.com

• UK Financial Ltd Executes Compliance Tasks Ahead Of First-Ever ERC-3643 Exchange-Traded Token, SMCAT & Sets Date For Online Investor Governance Vote
• TheOneLofi2: New Home for Chill Lo-Fi Hip Hop Beats Launches on YouTube
• eJoule Inc Participates in Silicon Dragon CES 2026
• HBZBZL Unveils "Intelligent Ecosystem" Strategy: Integrating AI Analytics with Web3 Incubation
• Kaltra Launches Next-Gen MCHEdesign With Full Integration Into MCHEselect — Instant Simulation & Seamless Microchannel Coil Workflow

The Companies expect to get funding in parts from Canadian government programs being deployed to help the country rebound from the covid-19 pandemic. The company will be resuming regular reporting and filing on OTC Markets. We have reduced the number of shares issued and outstanding by more than 25% in 2019 and will continue our policy of OS reduction going forward.

About VisualMED Clinical Solutions

VisualMED,  a clinical information company, owns a portfolio of valuable intellectual property. The company and its partners' university affiliates are world leaders in Artificial Intelligence which help to support our process to create intelligent applications for home use. Patients will be able to monitor serious health and medical issues, helping to reduce medical errors and negligence that put millions of patients in harm's way every year in North America.

About Advanced Intelligence Medicorum Solutions Inc

The Company is using database, knowledge, experience and partnerships with Montreal's leading AI experts to create health applications using artificial intelligence and deep learning to save lives and save money.

More on nvtip.com

• A Well-Fed World, Youth Climate Save and PAN International Launch PHRESH: A Global Directory of Plant-Based Hunger Relief Organizations
• New Year, New Space: How Las Vegas Residents are Resetting Their Homes for 2026
• Guests Can Save 25 Percent Off Last Minute Bookings at KeysCaribbean's Village at Hawks Cay Villas
• Trump's Executive Order Rescheduling Cannabis: Accelerating M&A in a Multibillion-Dollar Industry
• Genuine Hospitality, LLC Selected to Operate Hilton Garden Inn Birmingham SE / Liberty Park

Contact Information:

VisualMED Clinical Solutions
cliniscience@gmail.com
1-438-501-6500

FORWARD-LOOKING STATEMENTS: Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results.